Cargando…

Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression

This study aimed to investigate the association of add-on dipeptidyl peptidase-4 inhibitor (DPP4i) therapy and the progression of diabetic retinopathy (DR). In this retrospective population-based cohort study, we examined Taiwanese patients with type 2 diabetes, preexisting DR, and aged ≥40 years fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Eugene Yu-Chuan, Kang, Chunya, Wu, Wei-Chi, Sun, Chi-Chin, Chen, Kuan-Jen, Lai, Chi-Chun, Chen, Tien-Hsing, Hwang, Yih-Shiou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269314/ https://www.ncbi.nlm.nih.gov/pubmed/34203446 http://dx.doi.org/10.3390/jcm10132871

Ejemplares similares

Comparison of RetCam and Smartphone-Based Photography for Retinopathy of Prematurity Screening
por: Lin, Jui-Yen, et al.
Publicado: (2022)

Associations of VEGF Polymorphisms With Retinopathy of Prematurity
por: Ling, Xiao Chun, et al.
Publicado: (2023)

Persistent Vascular Anomalies in Retinopathy of Prematurity Children: Ultrawide-field Fluorescein Angiography Findings until School Age
por: Ling, Xiao Chun, et al.
Publicado: (2023)

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study
por: Chen, Yi-Chuan, et al.
Publicado: (2020)

Foveal hypoplasia and characteristics of optical components in patients with familial exudative vitreoretinopathy and retinopathy of prematurity
por: Chen, Pei-Ying, et al.
Publicado: (2022)

Effects of TIMP-2 Polymorphisms on Retinopathy of Prematurity Risk, Severity, Recurrence, and Treatment Response
por: Wu, Pei-Liang, et al.
Publicado: (2022)

Data Homogeneity Effect in Deep Learning-Based Prediction of Type 1 Diabetic Retinopathy
por: Lo, Jui-En, et al.
Publicado: (2021)

Surgical decisions and outcomes of rhegmatogenous retinal detachment during the coronavirus disease 2019 pandemic: Data from a tertiary referral center in Taiwan
por: Wu, Po-Yi, et al.
Publicado: (2023)

Dipeptidyl Peptidase 4 Stimulation Induces Adipogenesis-Related Gene Expression of Adipose Stromal Cells
por: Lai, Hsiao-Chi, et al.
Publicado: (2023)

Systemic Cytokines in Retinopathy of Prematurity
por: Wu, Po-Yi, et al.
Publicado: (2023)

Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes
por: Liao, Wen-Ling, et al.
Publicado: (2017)

Proposed measures to be taken by ophthalmologists during the coronavirus disease 2019 pandemic: Experience from Chang Gung Memorial Hospital, Linkou, Taiwan
por: Lin, Jui-Yen, et al.
Publicado: (2020)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

Retrospective Analysis of Surgical Outcomes on Axial Length Elongation in Eyes with Posterior and Combined Persistent Fetal Vasculature
por: Huang, Heng-Chiao, et al.
Publicado: (2023)

Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients
por: Li, Peng-Fei, et al.
Publicado: (2022)

Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis
por: Lee, Sahmin, et al.
Publicado: (2020)

Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
por: Chen, Kuan-Chan, et al.
Publicado: (2020)

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice
por: Komeno, Masahiro, et al.
Publicado: (2021)

Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes
por: Bae, Jaehyun, et al.
Publicado: (2022)

Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis
por: Jeon, Won Kyeong, et al.
Publicado: (2021)

Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin
por: Kim, Ye An, et al.
Publicado: (2015)

Deep Learning–Based Detection of Early Renal Function Impairment Using Retinal Fundus Images: Model Development and Validation
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
por: Lee, Minyoung, et al.
Publicado: (2020)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

The influence of dipeptidyl peptidase-4 inhibitor on the progression of type B intramural hematoma
por: Chen, Qu, et al.
Publicado: (2022)

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2023)

Correction to: “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”
por: Jeon, Won Kyeong, et al.
Publicado: (2022)

Infection Sources and Klebsiella pneumoniae Antibiotic Susceptibilities in Endogenous Klebsiella Endophthalmitis
por: Chen, Kuan-Jen, et al.
Publicado: (2022)

Eye irrigation as a first-line treatment and diagnostic method for emergency department patients who complain of ocular foreign bodies
por: Chou, Hung-Da, et al.
Publicado: (2021)

Evolutionary Analysis of Dipeptidyl Peptidase I
por: Varda, Nina, et al.
Publicado: (2022)

Dipeptidyl Peptidase-4 Inhibition May Stimulate Progression of Carcinoid Tumor
por: Pech, Vladimir, et al.
Publicado: (2015)

Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review
por: Singh, Awadhesh Kumar, et al.
Publicado: (2016)

Nasal Methicillin-Resistant Staphylococcus aureus Colonization in Patients with Type 1 Diabetes in Taiwan
por: Kang, Chun-Ya, et al.
Publicado: (2021)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
por: Lin, Tzu-Yi, et al.
Publicado: (2023)

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
por: Kim, Na-Hyung, et al.
Publicado: (2014)

Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
por: Shi, Sen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fmr5mm0odtnc7do45i1unsra6h